Kourtney Kardashian's supplement brand, Lemme, launched in September 2022 with the stated aim of offering “science-backed” vitamins and botanical supplements. Known as the most health-conscious of the Kar-Jenner sisters, Kourtney's interest in wellness deepened after the birth of her eldest son, Mason. However, despite her brand's mission, Lemme has faced significant criticism for several of its products, including an “Ozempic-style” weight-loss supplement, vagina gummies, and anti-cellulite capsules, with both fans and medical experts slamming the company for making unproven claims and exploiting body image insecurities.

One of the most recent and controversial launches is Lemme's GLP-1 Daily, marketed as an “Ozempic-style” weight-loss supplement. Ozempic, originally a diabetes medicine, gained popularity as a weight-loss aid due to its active ingredient, a synthetic version of the GLP-1 hormone, which slows digestion and reduces hunger. While Lemme’s GLP-1 Daily directly references this hormone, it uses lemon and saffron extracts to naturally boost GLP-1 levels over time, rather than containing the synthetic GLP-1 found in pharmaceutical drugs like Ozempic. The brand claims the supplement is designed to “reduce body weight, visceral fat, and hip and waist circumference” and has been promoted as a “GLP-1 solution without the side effects” of the injectable drug. However, this marketing has drawn heavy criticism. Fans accused Kourtney of a “facade” and “false marketing,” arguing that oral supplements cannot mimic the effects of GLP-1 medications for weight loss. Medical professionals, including plastic surgeon Naveen Cavale, echoed these concerns, stating that the supplement lacks scientific backing for significant weight loss and calling it “incredibly misleading” and a “cash grab.” Cavale warned that such products can create false hope and exacerbate mental health issues like anxiety and depression if they fail to deliver results. It is crucial to note that Ozempic contains semaglutide, a rigorously tested and FDA-approved GLP-1 receptor, whereas Lemme’s product lacks this key ingredient. Furthermore, Lemme's own small print reveals its claims have not been evaluated by the Food and Drug Administration (FDA), and the product is explicitly “not intended to diagnose, treat, cure or prevent any disease.”

Beyond the weight-loss supplement, Lemme has faced scrutiny for other products. Its “Lemme Purr” vagina gummies, launched in February last year, claimed to boost vaginal health and alter its taste using ingredients like pineapple, Vitamin C, and probiotics. This product was fiercely criticized by gynecologist Dr. Jen Gunter, author of “The Vagina Bible,” who called it a “grift” and condemned any suggestion that a vagina isn't fresh or needs an improved taste as misogynistic. She also disputed the idea that consuming pineapples affects bodily fluid taste.

Another product, Lemme Smooth capsules, launched in June, promised to reduce cellulite in just 28 days using French Cantaloupe Melon extract (SOD B Dimpless). Again, medical experts like Naveen Cavale dismissed these claims, labeling the product a “fad” and an “ineffective solution” for a perfectly normal skin condition. Cellulite is a common, harmless physiological occurrence, and doctors urge women not to fall for “miracle cures.” Cavale emphasized that these pills lack scientific backing and encouraged a holistic approach to body image and health instead. Like the GLP-1 Daily, Lemme Smooth's claims are not FDA-evaluated, with a similar disclaimer provided.

The recurring theme in the criticisms against Lemme's products is the perceived exploitation of women's insecurities and societal pressures to conform to unrealistic body standards. Experts argue that by offering expensive, quick-fix solutions without robust scientific evidence or FDA approval, Lemme risks harming consumers both financially and psychologically, fostering false hope and potentially worsening body image issues.